Works matching IS 2574173X AND DT 2022 AND VI 42 AND IP 3

Results: 25

A case of schizophrenia with congenital color vision deficiency: From the perspective of color universal design to promote medication adherence.

Published in:

Neuropsychopharmacology Reports, 2022, v. 42, n. 3, p. 384, doi. 10.1002/npr2.12278

By:

Miyazaki, Kensuke;
Uchiyama, Michiko;
Tsushima, Chieko;
Fujimoto, Kentarou

Publication type:

Article

Asymptomatic syndrome of inappropriate secretion of antidiuretic hormone (SIADH) following duloxetine treatment for pain with depression: Two case reports.

Published in:

Neuropsychopharmacology Reports, 2022, v. 42, n. 3, p. 387, doi. 10.1002/npr2.12279

By:

Sato, Aoi;
Yasui‐Furukori, Norio;
Oda, Yumiko;
Yang, Misa;
Suzuki, Yudai;
Shinozaki, Masataka;
Shimizu, Taro;
Shimoda, Kazutaka

Publication type:

Article

A case of mood disorder with severe side effects of antidepressants in association with resistance to thyroid hormone beta with a THRB mutation.

Published in:

Neuropsychopharmacology Reports, 2022, v. 42, n. 3, p. 391, doi. 10.1002/npr2.12280

By:

Komahashi‐Sasaki, Hazuki;
Yasui‐Furukori, Norio;
Maehara, Ryo;
Hasegawa, Chie;
Shimoda, Kazutaka

Publication type:

Article

Oxytocin treatment improves dexamethasone‐induced depression‐like symptoms associated with enhancement of hippocampal CREB‐BDNF signaling in female mice.

Published in:

Neuropsychopharmacology Reports, 2022, v. 42, n. 3, p. 356, doi. 10.1002/npr2.12271

By:

Mori, Masayoshi;
Shizunaga, Hiromi;
Harada, Hiroyoshi;
Tajiri, Yuki;
Murata, Yusuke;
Terada, Kazuki;
Ohe, Kenji;
Enjoji, Munechika

Publication type:

Article

EEG correlates of quality of life and associations with seizure without awareness and depression in patients with epilepsy.

Published in:

Neuropsychopharmacology Reports, 2022, v. 42, n. 3, p. 333, doi. 10.1002/npr2.12276

By:

Azuma, Hideki;
Akechi, Tatsuo

Publication type:

Article

Corrigendum.

Published in:: Neuropsychopharmacology Reports, 2022, v. 42, n. 3, p. 395, doi. 10.1002/npr2.12270
Publication type:: Article

Establishment to measure oxycodone in plasma with liquid chromatography–tandem mass spectrometry.

Published in:

Neuropsychopharmacology Reports, 2022, v. 42, n. 3, p. 299, doi. 10.1002/npr2.12268

By:

Ito, Suguru;
Mori, Masato;
Matsuo, Momoka;
Yamasaki, Rio;
Oida, Yasuhisa;
Soda, Midori;
Kitaichi, Kiyoyuki

Publication type:

Article

Effects of a web‐based relapse prevention program on abstinence: Secondary subgroup analysis of a pilot randomized controlled trial.

Published in:

Neuropsychopharmacology Reports, 2022, v. 42, n. 3, p. 362, doi. 10.1002/npr2.12272

By:

Takano, Ayumi;
Miyamoto, Yuki;
Shinozaki, Tomohiro;
Matsumoto, Toshihiko;
Kawakami, Norito

Publication type:

Article

Prolonged extrapyramidal symptoms induced by long‐term, intermittent administration of low‐dose olanzapine along with metoclopramide for emesis: A case report.

Published in:

Neuropsychopharmacology Reports, 2022, v. 42, n. 3, p. 380, doi. 10.1002/npr2.12277

By:

Sakamoto, Shoko;
Deguchi, Yasuhiko;
Uchida, Sawako;
Itoh, Yoshiaki;
Inoue, Koki

Publication type:

Article

Baseline risk characterization of early versus later adopters of long‐acting paliperidone palmitate formulations.

Published in:

Neuropsychopharmacology Reports, 2022, v. 42, n. 3, p. 347, doi. 10.1002/npr2.12260

By:

Fife, Daniel;
Fortin, Stephen;
Qiu, Hong;
Yamazaki, Michiyo;
Najarian, Dean;
Voss, Erica A

Publication type:

Article

Anodal transcranial direct current stimulation sustainably increases EEG alpha activity in patients with schizophrenia.

Published in:

Neuropsychopharmacology Reports, 2022, v. 42, n. 3, p. 323, doi. 10.1002/npr2.12274

By:

Pross, Benjamin;
Strube, Wolfgang;
Papazova, Irina;
Güler, Duygu;
Häckert, Jan;
Keeser, Daniel;
Padberg, Frank;
Siamouli, Melina;
Falkai, Peter;
Hasan, Alkomiet

Publication type:

Article

Reliability and validity of the Arabic version of the biological rhythms interview of assessment in neuropsychiatry.

Published in:

Neuropsychopharmacology Reports, 2022, v. 42, n. 3, p. 315, doi. 10.1002/npr2.12273

By:

Murad, Odeh S.;
Al‐Dassean, Khaled A.

Publication type:

Article

Effect of CNTNAP2 polymorphism on receptive language in children with autism spectrum disorder without language developmental delay.

Published in:

Neuropsychopharmacology Reports, 2022, v. 42, n. 3, p. 352, doi. 10.1002/npr2.12267

By:

Shiota, Yuka;
Hirosawa, Tetsu;
Yoshimura, Yuko;
Tanaka, Sanae;
Hasegawa, Chiaki;
Iwasaki, Sumie;
Sano, Masuhiko;
An, Kyung‐min;
Yokoyama, Shigeru;
Kikuchi, Mitsuru

Publication type:

Article

Residual effects of low dose of suvorexant, zolpidem, and ramelteon in healthy elderly subjects: A randomized double‐blind study.

Published in:

Neuropsychopharmacology Reports, 2022, v. 42, n. 3, p. 288, doi. 10.1002/npr2.12262

By:

Uemura, Sachiko Ito;
Imanishi, Aya;
Terui, Yoshino;
Park, Insung;
Satake, Masahiro;
Han, GoEun;
Shioya, Takanobu;
Kanbayashi, Takashi;
Nishino, Seiji

Publication type:

Article

Correlation of BDNF, VEGF, TNF‐α, and S100B with cognitive impairments in chronic, medicated schizophrenia patients.

Published in:

Neuropsychopharmacology Reports, 2022, v. 42, n. 3, p. 281, doi. 10.1002/npr2.12261

By:

Chukaew, Phatcharee;
Bunmak, Nutthaya;
Auampradit, Natchaphon;
Siripaiboonkij, Apinya;
Saengsawang, Witchuda;
Ratta‐apha, Woraphat

Publication type:

Article

Development and acceptability of a decision aid for major depressive disorder considering discontinuation of antidepressant treatment after remission.

Published in:

Neuropsychopharmacology Reports, 2022, v. 42, n. 3, p. 306, doi. 10.1002/npr2.12269

By:

Aoki, Yumi;
Takaesu, Yoshikazu;
Baba, Hajime;
Iga, Jun‐ichi;
Hori, Hikaru;
Inoue, Takeshi;
Mishima, Kazuo;
Tajika, Aran;
Kato, Masaki

Publication type:

Article

Lurasidone‐induced hyperosmolar hyperglycemic syndrome: A case report.

Published in:

Neuropsychopharmacology Reports, 2022, v. 42, n. 3, p. 377, doi. 10.1002/npr2.12259

By:

Hanyu, Shota;
Kojima, Yusuke;
Murai, Toshiya;
Kawashima, Hirotsugu

Publication type:

Article

Interaction between social behavior and paternal age in offspring of the same paternal mice.

Published in:

Neuropsychopharmacology Reports, 2022, v. 42, n. 3, p. 343, doi. 10.1002/npr2.12258

By:

Tanaka, Miho;
Sato, Atsushi;
Kotajima‐Murakami, Hiroko;
Kashii, Hirofumi;
Hagino, Yoko;
Ide, Soichiro;
Ikeda, Kazutaka

Publication type:

Article

Effects of high‐fat diet on nutrient metabolism and cognitive functions in young APPKI<sup>NL‐G‐F/NL‐G‐F</sup> mice.

Published in:

Neuropsychopharmacology Reports, 2022, v. 42, n. 3, p. 272, doi. 10.1002/npr2.12257

By:

Wang, Wei;
Tanokashira, Daisuke;
Shibayama, Yudai;
Tsuji, Ryuhei;
Maruyama, Megumi;
Kuroiwa, Chiemi;
Saito, Takashi;
Saido, Takaomi C.;
Taguchi, Akiko

Publication type:

Article

Perospirone augmentation of escitalopram in the treatment of an adolescent sophophobia (fear of learning) patient.

Published in:: Neuropsychopharmacology Reports, 2022, v. 42, n. 3, p. 374, doi. 10.1002/npr2.12256
Publication type:: Article

Issue Information.

Published in:: Neuropsychopharmacology Reports, 2022, v. 42, n. 3, p. 247, doi. 10.1002/npr2.12186
Publication type:: Article

Relationship between the early repolarization pattern and a history of suicide attempts among drug‐free psychiatric patients.

Published in:

Neuropsychopharmacology Reports, 2022, v. 42, n. 3, p. 256, doi. 10.1002/npr2.12254

By:

Kameyama, Hiroshi;
Sugimoto, Kenichi;
Kodaka, Fumitoshi;
Ito, Kyoko;
Nukariya, Kazutaka;
Kato, Tomohiro;
Shigeta, Masahiro

Publication type:

Article

Identification of factors associated with the efficacy of atomoxetine in adult attention‐deficit/hyperactivity disorder.

Published in:

Neuropsychopharmacology Reports, 2022, v. 42, n. 3, p. 249, doi. 10.1002/npr2.12253

By:

Nagai, Tsutomu;
Kurihara, Tatsuya;
Koya, Hiroaki;
Nakano, Yukako;
Sugisawa, Satoru;
Sambe, Takehiko;
Kishimoto, Keiko;
Kogo, Mari;
Ota, Haruhisa;
Iwanami, Akira;
Uchida, Naoki

Publication type:

Article

Fluphenazine decanoate‐induced bradycardia: A case report.

Published in:

Neuropsychopharmacology Reports, 2022, v. 42, n. 3, p. 368, doi. 10.1002/npr2.12251

By:

Kamali, Mahsa;
Zarghami, Mehran;
Azizi, Marzieh;
Elyasi, Forouzan

Publication type:

Article

Prenatal methotrexate injection increases behaviors possibly associated with depression and/or autism in rat offspring; A new animal model for mental disorder, based on folate metabolism deficit during pregnancy.

Published in:

Neuropsychopharmacology Reports, 2022, v. 42, n. 3, p. 263, doi. 10.1002/npr2.12255

By:

Amada, Naoki;
Kakumoto, Yusuke;
Futamura, Takashi;
Maeda, Kenji

Publication type:

Article